ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 651593 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 651593; 2) Community: the network communities that were significantly associated with the response to NSC 651593; 3) Molecule: the relationships between components within communities and NSC 651593; 4) MDR: the compounds that were significantly associated with the NSC 651593.

NSC Compound Enrichment Correlation
NSC 628946 Null 0.000573863872925603 0.34605042
NSC 50273 Pyridine, 3-[[4-[bis(2-chloroethyl)amino]-2-methylbenzylidene]amino]- 0.000602374785885765 0.1246354
NSC 646233 Null 0.000602374785885765 0.16954477
NSC 664343 Null 0.000602374785885774 0.20485819
NSC 708048 2-Butenoic acid, 4,4-dicyano-4-[[(3-thienyl)methylene]amino]-, ethyl ester, (2Z,1E)- 0.000610795106687072 0.81626467
NSC 709362 Acetamide, N,N'-(1,5-pentanediyl)bis[2-(1,3,5,11a-tetrahydro- 5-oxopyrrolo[2,1-c][1,4]benzodiazepin-2-ylidene)- 0.000610795106687072 0.71156431
NSC 714636 Null 0.000610795106687072 0.30178639
NSC 735169 3-(3,5-Bis-trifluoromethyl-phenylsulfanyl)-1-(4-chloro-pheny l)-propenone 0.000610795106687072 0.50072534
NSC 135073 WITHACNISTIN 0.000610795106687085 0.57396226
NSC 144163 Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- 0.000610795106687085 0.58693306
Total:114  Current:5    [First] [Prev] [Next] [Last]